Search Results 931-940 of 14037 for 78%

  1. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors - Mayo Clinic

    Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 ...

  2. Publications - Scott Wright, M.D. - Mayo Clinic

    2014 Sep; 89(9):1257-78. Epub 2014 Aug 12. View PubMed; Nicholls SJ, Kastelein JJ, Schwartz GG, Bash D, Rosenson RS, Cavender MA, Brennan DM, Koenig W ...

  4. Paced Breathing Training on Blood Pressure Regulation - Mayo Clinic

    About this study. The mian objective of this small pilot study is to evaluate the efficacy of an individualized breathing protocol on lowering blood ...

  5. Occult Gastrointestinal Bleeding in Non-pulsatile Left Ventricular Assist Device (VAD) Patients - Mayo Clinic

    The purpose of this study is to estimate the proportion of Ventricular Assist Device (VAD) patients with abnormal gastrointestinal bleeding as assessed by ...

  6. Breast cancer - Doctors and departments - Mayo Clinic

    78 Replies Sun, Apr 27, 2025. walkingmom · Mouth Sores from chemo: When do they go away? 81 Replies Fri, Apr 25, 2025. See more discussions. Related. Breast ...

  7. Technical Reports - Department of Quantitative Health Sciences - Mayo Clinic Research

    78. Estimating Genetic Components of Variance for Quantitative Traits in Family Studies Using the MULTIC Routines (PDF). This report provides an overview of ...

  8. Genetic Expression in Osteolysis, Infection, Arthrofibrosis & Metal Reactions in THA & TKA: A Microarray Analysis to Characterize Individual Host Response to the Molecular Mechanisms of Loosening and Arthrofibrosis - Mayo Clinic

    This study is being conducted to determine gene and protein expression profiles (i.e. which genes and proteins are turned off and on) of those with a ...

  9. Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation - Mayo Clinic

    Recent reports have identified a specific oncogenic mutation L265P of the MYD88 gene in approximately 30% of the patients with the activated B-cell (ABC) type ...

  10. Gastroenterology and Hepatology - Clinical trials

    Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. It is ...